Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H46O4 |
InChIKeyAXZXYLZESSVCIQ-VFXFBGGWSA-N |
CAS Registry139137-06-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | Denmark | 01 Sep 1993 |





